Malaria Vaccine Introduction in Cameroon: Early Results 30 Days into Rollout
Vaccines · 22.03.2024 · 12 (4) · 346
DOI: 10.3390/vaccines12040346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 22.03.2024. Verfasst von Shalom Tchokfe Ndoula und 15 weiteren Autor:innen. Beteiligte Einrichtung: Expanded Program on Immunization, Ministry of Public Health, Yaoundé P.O. Box 1937, Cameroon. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.
Abstract (Originalsprache)
Cameroon introduced the malaria vaccine in its routine immunization program on 22 January 2024 in the 42 districts out of 200 that are among the most at risk of malaria. A cross-sectional analysis of the data on key vaccine events in the introduction roadmap and the vaccine uptake during the first 30 days was conducted. In addition to available gray literature related to the introduction of the malaria vaccine, data on the malaria vaccine uptake by vaccination session, collected through a digital platform, were analyzed. A total of 1893 reports were received from 22 January 2024 to 21 February 2024 from 766 health facilities (84% of overall completeness). Two regions out of ten recorded less than 80% completeness. As of 21 February 2024, 13,811 children had received the first dose of the malaria vaccine, including 7124 girls (51.6%) and 6687 boys (48.4%). In total, 36% of the children were vaccinated through outreach sessions, while 61.5% were vaccinated through sessions in fixed posts. The overall monthly immunization coverage with the first dose was 37%. Early results have shown positive attitudes towards and acceptance of malaria vaccines. Suboptimal completeness of data reporting and a low coverage highlight persistent gaps and challenges in the vaccine rollout.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Expanded Program on Immunization, Ministry of Public Health, Yaoundé P.O. Box 1937, Cameroon.
- World Health Organization Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
- School of Global Health and Bioethics, Euclid University, Bangui P.O. Box 157, Central African Republic.
- World Health Organization Country Office, P.O. Box 155 Yaoundé, Cameroon.
ORCID-Profile: Shalom Tchokfe Ndoula, Frank Mboussou, Adidja Amani, Bridget Farham
Förderung
- World Health Organization
Zitieren
APA
Ndoula, S. T., Mboussou, F., Njoh, A. A., Nembot, R., Baonga, S. F., Njinkeu, A., Biey, J., Kaba, M. I., Amani, A., Farham, B., Kouontchou Mimbe, J. C., Kouakam, C. A., Volkmann, K., Dadjo, C. H., Habimana, P., & Impouma, B. (2024). Malaria Vaccine Introduction in Cameroon: Early Results 30 Days into Rollout. Vaccines, 12(4), 346. https://doi.org/10.3390/vaccines12040346
Vancouver
Ndoula ST, Mboussou F, Njoh AA, Nembot R, Baonga SF, Njinkeu A, et al. Malaria Vaccine Introduction in Cameroon: Early Results 30 Days into Rollout. Vaccines. 2024;12(4):346. doi:10.3390/vaccines12040346
BibTeX
@article{Ndoula2024,
author = {Ndoula, Shalom Tchokfe and Mboussou, Frank and Njoh, Andreas Ateke and Nembot, Raoul and Baonga, Simon Franky and Njinkeu, Arnaud and Biey, Joseph and Kaba, Mohamed Ii and Amani, Adidja and Farham, Bridget and Kouontchou Mimbe, Jean-Christian and Kouakam, Christian Armel and Volkmann, Konstantin and Dadjo, Crépin Hilaire and Habimana, Phanuel and Impouma, Benido},
title = {Malaria Vaccine Introduction in Cameroon: Early Results 30 Days into Rollout},
journal = {Vaccines},
year = {2024},
volume = {12},
number = {4},
pages = {346},
doi = {10.3390/vaccines12040346}
}
EUVIMED